The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coli
Open accessAbstract
BACKGROUND: Artemisinin derivatives are the key active ingredients in Artemisinin combination therapies (ACTs), the most effective therapies available for treatment of malaria. Because the raw material is extracted from plants with long growing seasons, artemisinin is often in short supply, and fermentation would be an attractive alternative production method to supplement the plant source. Previous work showed that high levels of amorpha-4,11-diene, an artemisinin precursor, can be made in Escherichia coli using a heterologous mevalonate pathway derived from yeast (Saccharomyces cerevisiae), though the reconstructed mevalonate pathway was limited at a particular enzymatic step. METHODOLOGY/ PRINCIPAL FINDINGS: By combining improvements in the heterologous mevalonate pathway with a superior fermentation process, commercially relevant titers were achieved in fed-batch fermentations. Yeast genes for HMG-CoA synthase and HMG-CoA reductase (the second and third enzymes in the pathway) were replaced with equivalent genes from Staphylococcus aureus, more than doubling production. Amorpha-4,11-diene titers were further increased by optimizing nitrogen delivery in the fermentation process. Successful cultivation of the improved strain under carbon and nitrogen restriction consistently yielded 90 g/L dry cell weight and an average titer of 27.4 g/L amorpha-4,11-diene. CONCLUSIONS/ SIGNIFICANCE: Production of >25 g/L amorpha-4,11-diene by fermentation followed by chemical conversion to artemisinin may allow for development of a process to provide an alternative source of artemisinin to be incorporated into ACTs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
Studies on transformation of Escherichia coli with plasmids
Hanahan, D. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80284-8 · Cited by 11,157
Weltgesundheitsorganisation (2005) · Cited by 3,799
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006) · Nature · doi:10.1038/nature04640 · Cited by 2,805
Self-citationEngineering a mevalonate pathway in Escherichia coli for production of terpenoids
Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D., & Keasling, J. D. (2003) · Nature Biotechnology · doi:10.1038/nbt833 · Cited by 1,725
Self-citationQinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954
Simple fed-batch technique for high cell density cultivation of Escherichia coli
Korz, D. J., Rinas, U., Hellmuth, K., Sanders, E. A., & Deckwer, W.-D. (1995) · Journal of Biotechnology · doi:10.1016/0168-1656(94)00143-z · Cited by 445
Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli
Pitera, D. J., Paddon, C. J., Newman, J. D., & Keasling, J. D. (2007) · Metabolic Engineering · doi:10.1016/j.ymben.2006.11.002 · Cited by 438
Self-citationAlper, H., Miyaoku, K., & Stephanopoulos, G. (2005) · Nature Biotechnology · doi:10.1038/nbt1083 · Cited by 433
Teoh, K. H., Polichuk, D. R., Reed, D. W., Nowak, G., & Covello, P. S. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.065 · Cited by 409
Engineering Escherichia coli for production of functionalized terpenoids using plant P450s
Chang, M. C. Y., Eachus, R. A., Trieu, W., Ro, D.-K., & Keasling, J. D. (2007) · Nature Chemical Biology · doi:10.1038/nchembio875 · Cited by 364
Self-citation(1972) · Medicinal Chemistry · doi:10.1016/b978-0-12-688950-5.50009-x · Cited by 301
Anthony, J. R., Anthony, L. C., Nowroozi, F., Kwon, G., Newman, J. D., & Keasling, J. D. (2009) · Metabolic Engineering · doi:10.1016/j.ymben.2008.07.007 · Cited by 292
Self-citationNewman, J. D., Marshall, J., Chang, M., Nowroozi, F., Paradise, E., Pitera, D., Newman, K. L., & Keasling, J. D. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21017 · Cited by 257
Recombinant Protein Expression in High Cell Density Fed-Batch Cultures of Escherichia Coli
Yee, L., & Blanch, H. W. (1992) · Nature Biotechnology · doi:10.1038/nbt1292-1550 · Cited by 255
Geiser, M., Cébe, R., Drewello, D., & Schmitz, R. (2001) · BioTechniques · doi:10.2144/01311st05 · Cited by 247
White, N. J. (1998) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011721 · Cited by 226
Application of Functional Genomics to Pathway Optimization for Increased Isoprenoid Production
Kizer, L., Pitera, D. J., Pfleger, B. F., & Keasling, J. D. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02750-07 · Cited by 178
Self-citationTang, W., & Eisenbrand, G. (1992) · Chinese Drugs of Plant Origin · doi:10.1007/978-3-642-73739-8_22 · Cited by 158
Hale, V., Keasling, J. D., Renninger, N. S., & Diagana, T. T. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.198 · Cited by 132
Self-citationHIGH CELL DENSITY CULTIVATION OF ESCHERICHIA COLI
Lee, S. Y. (1996) · Cited by 129
Rozkov, A., Avignone-Rossa, C. A., Ertl, P. F., Jones, P., O’Kennedy, R. D., Smith, J. J., Dale, J. W., & Bushell, M. E. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20327 · Cited by 122
Lenihan, J. R., Tsuruta, H., Diola, D., Renninger, N. S., & Regentin, R. (2008) · Biotechnology Progress · doi:10.1002/btpr.27 · Cited by 87
Self-citationWilding, E. I., Kim, D.-Y., Bryant, A. P., Gwynn, M. N., Lunsford, R. D., McDevitt, D., Myers, J. E., Rosenberg, M. J., Sylvester, D., Stauffacher, C. V., et al. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.18.5147-5152.2000 · Cited by 80
Shang, F., Wen, S., Wang, X., & Tan, T. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.11.020 · Cited by 68
Production of mevalonate by a metabolically-engineered Escherichia coli
Tabata, K., & Hashimoto, S. (2004) · Biotechnology Letters · doi:10.1023/b:bile.0000044449.08268.7d · Cited by 65
Class II 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductases
Hedl, M., Tabernero, L., Stauffacher, C. V., & Rodwell, V. W. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.7.1927-1932.2004 · Cited by 64
Cited by
Microbial production of fatty-acid-derived fuels and chemicals from plant biomass
Steen, E. J., Kang, Y., Bokinsky, G., Hu, Z., Schirmer, A., McClure, A., del Cardayre, S. B., & Keasling, J. D. (2010) · Nature · doi:10.1038/nature08721 · Cited by 1,342
Self-citationMicrobial engineering for the production of advanced biofuels
Peralta-Yahya, P. P., Zhang, F., del Cardayre, S. B., & Keasling, J. D. (2012) · Nature · doi:10.1038/nature11478 · Cited by 1,097
Self-citationWestfall, P. J., Pitera, D. J., Lenihan, J. R., Eng, D., Woolard, F. X., Regentin, R., Horning, T., Tsuruta, H., Melis, D. J., Owens, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110740109 · Cited by 722
Self-citationSemi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development
Paddon, C. J., & Keasling, J. D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3240 · Cited by 675
Self-citationIdentification and microbial production of a terpene-based advanced biofuel
Peralta-Yahya, P. P., Ouellet, M., Chan, R., Mukhopadhyay, A., Keasling, J. D., & Lee, T. S. (2011) · Nature Communications · doi:10.1038/ncomms1494 · Cited by 637
Self-citation
Metadata
- Authors
- Tsuruta, H., Paddon, C. J., Eng, D., Lenihan, J. R., Horning, T., Anthony, L. C., Regentin, R., Keasling, J. D., Renninger, N. S., & Newman, J. D.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-02-16
- Volume
- 4
- Issue
- 2
- Pages
- e4489
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2014968469
- Cited by
- 363
- References
- 27
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.